Business
The emerging wellness company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies....
Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL....
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents...
The PsycheDev app guides users through intention setting, meditation, learning, contemplation and questioning, serving as a virtual facilitator and integration...
The OTCQB is a middle-tier market for entrepreneurial and development stage American and international companies....
HUGE UPDATE: Compass Pathways, (NASDAQ: CMPS), completes the LARGEST Phase 2b psilocybin clinical study to treat treatment resistant depression (TRD)....
Anthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we...
The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as...
Numinus Wellness (TSX.V: NUMI), (OTC: LKYSF), has been a constant topic of conversation on this channel. NUMI is a company...
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal...